| Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus JS McLellan, M Chen, MG Joyce, M Sastry, GBE Stewart-Jones, Y Yang, ... science 342 (6158), 592-598, 2013 | 1055 | 2013 |
| Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 JS McLellan, M Pancera, C Carrico, J Gorman, JP Julien, R Khayat, ... Nature 480 (7377), 336-343, 2011 | 1055 | 2011 |
| Structure and immune recognition of trimeric pre-fusion HIV-1 Env M Pancera, T Zhou, A Druz, IS Georgiev, C Soto, J Gorman, J Huang, ... Nature 514 (7523), 455-461, 2014 | 857 | 2014 |
| Fragment-based identification of druggable ‘hot spots’ of proteins using Fourier domain correlation techniques R Brenke, D Kozakov, GY Chuang, D Beglov, D Hall, MR Landon, ... Bioinformatics 25 (5), 621-627, 2009 | 531 | 2009 |
| Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface J Huang, BH Kang, M Pancera, JH Lee, T Tong, Y Feng, H Imamichi, ... Nature 515 (7525), 138-142, 2014 | 519 | 2014 |
| Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite G Cerutti, Y Guo, T Zhou, J Gorman, M Lee, M Rapp, ER Reddem, J Yu, ... Cell host & microbe 29 (5), 819-833. e7, 2021 | 506 | 2021 |
| Trimeric HIV-1-Env structures define glycan shields from clades A, B, and G GBE Stewart-Jones, C Soto, T Lemmin, GY Chuang, A Druz, R Kong, ... Cell 165 (4), 813-826, 2016 | 441 | 2016 |
| Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera JO Ngwuta, M Chen, K Modjarrad, MG Joyce, M Kanekiyo, A Kumar, ... Science translational medicine 7 (309), 309ra162-309ra162, 2015 | 401 | 2015 |
| Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env Y Do Kwon, M Pancera, P Acharya, IS Georgiev, ET Crooks, J Gorman, ... Nature structural & molecular biology 22 (7), 522-531, 2015 | 388 | 2015 |
| Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies T Zhou, J Zhu, X Wu, S Moquin, B Zhang, P Acharya, IS Georgiev, ... Immunity 39 (2), 245-258, 2013 | 386 | 2013 |
| Identification of a CD4-binding-site antibody to HIV that evolved near-pan neutralization breadth J Huang, BH Kang, E Ishida, T Zhou, T Griesman, Z Sheng, F Wu, ... Immunity 45 (5), 1108-1121, 2016 | 367 | 2016 |
| Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody R Kong, K Xu, T Zhou, P Acharya, T Lemmin, K Liu, G Ozorowski, C Soto, ... Science 352 (6287), 828-833, 2016 | 352 | 2016 |
| Cryo-EM structures of SARS-CoV-2 spike without and with ACE2 reveal a pH-dependent switch to mediate endosomal positioning of receptor-binding domains T Zhou, Y Tsybovsky, J Gorman, M Rapp, G Cerutti, GY Chuang, ... Cell host & microbe 28 (6), 867-879. e5, 2020 | 348 | 2020 |
| Maturation pathway from germline to broad HIV-1 neutralizer of a CD4-mimic antibody M Bonsignori, T Zhou, Z Sheng, L Chen, F Gao, MG Joyce, G Ozorowski, ... Cell 165 (2), 449-463, 2016 | 330 | 2016 |
| Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses MG Joyce, AK Wheatley, PV Thomas, GY Chuang, C Soto, RT Bailer, ... Cell 166 (3), 609-623, 2016 | 325 | 2016 |
| Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo RS Rudicell, YD Kwon, SY Ko, A Pegu, MK Louder, IS Georgiev, X Wu, ... Journal of virology 88 (21), 12669-12682, 2014 | 318 | 2014 |
| Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1 K Xu, P Acharya, R Kong, C Cheng, GY Chuang, K Liu, MK Louder, ... Nature medicine 24 (6), 857-867, 2018 | 292 | 2018 |
| Structural conservation of druggable hot spots in protein–protein interfaces D Kozakov, DR Hall, GY Chuang, R Cencic, R Brenke, LE Grove, ... Proceedings of the National Academy of Sciences 108 (33), 13528-13533, 2011 | 279 | 2011 |
| A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite NK Kisalu, AH Idris, C Weidle, Y Flores-Garcia, BJ Flynn, BK Sack, ... Nature medicine 24 (4), 408-416, 2018 | 271 | 2018 |
| Maturation and diversity of the VRC01-antibody lineage over 15 years of chronic HIV-1 infection X Wu, Z Zhang, CA Schramm, MG Joyce, Y Do Kwon, T Zhou, Z Sheng, ... Cell 161 (3), 470-485, 2015 | 267 | 2015 |